364 related articles for article (PubMed ID: 32258827)
1. Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration.
Haug SJ; Hien DL; Uludag G; Ngoc TTT; Lajevardi S; Halim MS; Sepah YJ; Do DV; Khanani AM
Am J Ophthalmol Case Rep; 2020 Jun; 18():100680. PubMed ID: 32258827
[TBL] [Abstract][Full Text] [Related]
2. Severe vision loss secondary to retinal arteriolar occlusions after multiple intravitreal brolucizumab administrations.
Jain A; Chea S; Matsumiya W; Halim MS; Yaşar Ç; Kuang G; Sepah YJ; Khanani AM; Do DV; Nguyen QD
Am J Ophthalmol Case Rep; 2020 Jun; 18():100687. PubMed ID: 32280811
[TBL] [Abstract][Full Text] [Related]
3. Retinal arterial occlusive vasculitis after multiple intravitreal brolucizumab injections for diabetic macular edema.
Hirano T; Toriyama Y; Takahashi Y; Hoshiyama K; Murata T
Am J Ophthalmol Case Rep; 2023 Mar; 29():101788. PubMed ID: 36632338
[TBL] [Abstract][Full Text] [Related]
4. Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab.
Baumal CR; Spaide RF; Vajzovic L; Freund KB; Walter SD; John V; Rich R; Chaudhry N; Lakhanpal RR; Oellers PR; Leveque TK; Rutledge BK; Chittum M; Bacci T; Enriquez AB; Sund NJ; Subong ENP; Albini TA
Ophthalmology; 2020 Oct; 127(10):1345-1359. PubMed ID: 32344075
[TBL] [Abstract][Full Text] [Related]
5. Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER.
Monés J; Srivastava SK; Jaffe GJ; Tadayoni R; Albini TA; Kaiser PK; Holz FG; Korobelnik JF; Kim IK; Pruente C; Murray TG; Heier JS
Ophthalmology; 2021 Jul; 128(7):1050-1059. PubMed ID: 33207259
[TBL] [Abstract][Full Text] [Related]
6. Three cases of brolucizumab-associated retinal vasculitis treated with systemic and local steroid therapy.
Kataoka K; Horiguchi E; Kawano K; Ushida H; Nakano Y; Ito Y; Terasaki H
Jpn J Ophthalmol; 2021 Mar; 65(2):199-207. PubMed ID: 33543352
[TBL] [Abstract][Full Text] [Related]
7. Angiographic findings before and after the onset of brolucizumab-associated retinal vascular occlusion and intraocular inflammation.
Kusuhara S; Kim KW; Miki A; Nakamura M
Am J Ophthalmol Case Rep; 2022 Jun; 26():101521. PubMed ID: 35464682
[TBL] [Abstract][Full Text] [Related]
8. Short-Term Safety and Efficacy of Intravitreal Brolucizumab Injections for Neovascular Age-Related Macular Degeneration: A Multicenter Retrospective Real-World Study.
Kim DJ; Jin KW; Han JM; Lee SH; Park YS; Lee JY; Lee EK; Lee JS; Kim ST; Shin MH; Lee CS; Jung HH; Jang JY; Kim M; Kim YH; Kim JH; Park KH; Park SJ; Joo K; Ji YS; Sagong M; Woo SJ
Ophthalmologica; 2023; 246(3-4):192-202. PubMed ID: 36720210
[TBL] [Abstract][Full Text] [Related]
9. Expert Opinion on Management of Intraocular Inflammation, Retinal Vasculitis, and Vascular Occlusion after Brolucizumab Treatment.
Baumal CR; Bodaghi B; Singer M; Tanzer DJ; Seres A; Joshi MR; Feltgen N; Gale R
Ophthalmol Retina; 2021 Jun; 5(6):519-527. PubMed ID: 33007521
[TBL] [Abstract][Full Text] [Related]
10. Brolucizumab-related retinal vasculitis with exacerbation following ranibizumab retreatment: A clinicopathologic case study.
Iyer PG; Peden MC; Suñer IJ; Patel N; Dubovy SR; Albini TA
Am J Ophthalmol Case Rep; 2020 Dec; 20():100989. PubMed ID: 33294727
[TBL] [Abstract][Full Text] [Related]
11. Detection and Management of Intraocular Inflammation after Brolucizumab Treatment for Neovascular Age-Related Macular Degeneration.
Bodaghi B; Souied EH; Tadayoni R; Weber M; Ponthieux A; Kodjikian L
Ophthalmol Retina; 2023 Oct; 7(10):879-891. PubMed ID: 37343623
[TBL] [Abstract][Full Text] [Related]
12. Swept-source optical coherence tomography angiography of retinal occlusive vasculitis following brolucizumab administration: a case report.
Lee EK; Oh BL; Yoon CK; Park UC
BMC Ophthalmol; 2022 Jun; 22(1):244. PubMed ID: 35659269
[TBL] [Abstract][Full Text] [Related]
13. Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab.
Witkin AJ; Hahn P; Murray TG; Arevalo JF; Blinder KJ; Choudhry N; Emerson GG; Goldberg RA; Kim SJ; Pearlman J; Schneider EW; Tabandeh H; Wong RW
J Vitreoretin Dis; 2020 Jul; 4(4):269-279. PubMed ID: 32789284
[TBL] [Abstract][Full Text] [Related]
14. Central retinal artery occlusion after intravitreal brolucizumab injection for treatment-naïve neovascular age-related macular degeneration; a case report.
Hong SH; Kim HD
BMC Ophthalmol; 2024 Apr; 24(1):200. PubMed ID: 38679743
[TBL] [Abstract][Full Text] [Related]
15. INCIDENCE AND RISK FACTORS OF INTRAOCULAR INFLAMMATION AFTER BROLUCIZUMAB TREATMENT IN JAPAN: A Multicenter Age-Related Macular Degeneration Study.
Inoda S; Takahashi H; Maruyama-Inoue M; Ikeda S; Sekiryu T; Itagaki K; Matsumoto H; Mukai R; Nagai Y; Ohnaka M; Kusuhara S; Miki A; Okada AA; Nakayama M; Nishiguchi KM; Takeuchi J; Mori R; Tanaka K; Honda S; Kohno T; Koizumi H; Miyara Y; Inoue Y; Takana H; Iida T; Maruko I; Hayashi A; Ueda-Consolvo T; Yanagi Y
Retina; 2024 Apr; 44(4):714-722. PubMed ID: 38016089
[TBL] [Abstract][Full Text] [Related]
16. A CONSENSUS ON RISK MITIGATION FOR BROLUCIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Patient Selection, Evaluation, and Treatment.
Holz FG; Iida T; Maruko I; Sadda SR
Retina; 2022 Sep; 42(9):1629-1637. PubMed ID: 35994582
[TBL] [Abstract][Full Text] [Related]
17. Ocular adverse events following intravitreal brolucizumab for neovascular age-related macular degeneration at a single tertiary care center.
Nguyen HV; Li AS; Silva AR; Leng T
Eur J Ophthalmol; 2022 Sep; 32(5):2747-2751. PubMed ID: 34761684
[TBL] [Abstract][Full Text] [Related]
18. Real-World Frequency and Management of Ocular Adverse Events in Eyes with Neovascular Age-Related Macular Degeneration Treated with Brolucizumab.
Zubricky R; McCoy J; Donkor R; Miller DG; Sonbolian N; Heaney A; Bilano V; Karcher H; Coney JM
Ophthalmol Ther; 2023 Oct; 12(5):2397-2408. PubMed ID: 37310683
[TBL] [Abstract][Full Text] [Related]
19. Bilateral blindness after uneventful brolucizumab injection for macular degeneration.
Barchichat I; Thiel M; Job O; Schmid M
BMC Ophthalmol; 2022 Feb; 22(1):80. PubMed ID: 35172763
[TBL] [Abstract][Full Text] [Related]
20. Scleritis following intravitreal brolucizumab injection: a case series.
Takayama T; Inoda S; Takahashi H; Tsukii R; Yoshida H; Kasuya Y; Nagaoka K; Takahashi R; Arai Y; Kawashima H
J Med Case Rep; 2024 Feb; 18(1):80. PubMed ID: 38419100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
